| Dr Kristin Emily Berry, DO | |
|
340 Nw 5th St, Redmond, OR 97756-1869 | |
| (541) 526-6635 | |
| (541) 526-6636 |
| Full Name | Dr Kristin Emily Berry |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 340 Nw 5th St, Redmond, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306036314 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Charles Health System Inc | 8729111513 | 206 |
News Archive
CMC Biologics, Inc., a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, announced today that, as part of its global manufacturing capacity expansion strategy, it has completed the expansion of its North American manufacturing facility in Bothell, Washington with the addition of a single-use Bioreactor 6Pack™ facility.
Intense competition for posts has left many junior doctors (whose training costs around £237,000 each) without jobs to go to when their contracts end next Tuesday. Many are now considering leaving the country, abandoning the profession, or claiming unemployment benefit.
Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes.
Massachusetts has taken an important step towards addressing its primary care provider shortage. Recently passed legislation (Chapter 305), championed by Senate President Therese Murray, addresses issues of access, quality and transparency in health care. The recognition of nurse practitioners as primary care providers is vital to this legislation and will immediately and dramatically increase the number of providers available to residents.
CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved.
› Verified 7 days ago
| Entity Name | St Charles Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982621447 PECOS PAC ID: 3870402852 Enrollment ID: O20040112000045 |
News Archive
CMC Biologics, Inc., a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, announced today that, as part of its global manufacturing capacity expansion strategy, it has completed the expansion of its North American manufacturing facility in Bothell, Washington with the addition of a single-use Bioreactor 6Pack™ facility.
Intense competition for posts has left many junior doctors (whose training costs around £237,000 each) without jobs to go to when their contracts end next Tuesday. Many are now considering leaving the country, abandoning the profession, or claiming unemployment benefit.
Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes.
Massachusetts has taken an important step towards addressing its primary care provider shortage. Recently passed legislation (Chapter 305), championed by Senate President Therese Murray, addresses issues of access, quality and transparency in health care. The recognition of nurse practitioners as primary care providers is vital to this legislation and will immediately and dramatically increase the number of providers available to residents.
CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved.
› Verified 7 days ago
| Entity Name | St Charles Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023331303 PECOS PAC ID: 8729111513 Enrollment ID: O20100730000227 |
News Archive
CMC Biologics, Inc., a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, announced today that, as part of its global manufacturing capacity expansion strategy, it has completed the expansion of its North American manufacturing facility in Bothell, Washington with the addition of a single-use Bioreactor 6Pack™ facility.
Intense competition for posts has left many junior doctors (whose training costs around £237,000 each) without jobs to go to when their contracts end next Tuesday. Many are now considering leaving the country, abandoning the profession, or claiming unemployment benefit.
Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes.
Massachusetts has taken an important step towards addressing its primary care provider shortage. Recently passed legislation (Chapter 305), championed by Senate President Therese Murray, addresses issues of access, quality and transparency in health care. The recognition of nurse practitioners as primary care providers is vital to this legislation and will immediately and dramatically increase the number of providers available to residents.
CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved.
› Verified 7 days ago
| Entity Name | Obhg Oregon Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528585148 PECOS PAC ID: 2365776390 Enrollment ID: O20190626000182 |
News Archive
CMC Biologics, Inc., a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, announced today that, as part of its global manufacturing capacity expansion strategy, it has completed the expansion of its North American manufacturing facility in Bothell, Washington with the addition of a single-use Bioreactor 6Pack™ facility.
Intense competition for posts has left many junior doctors (whose training costs around £237,000 each) without jobs to go to when their contracts end next Tuesday. Many are now considering leaving the country, abandoning the profession, or claiming unemployment benefit.
Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes.
Massachusetts has taken an important step towards addressing its primary care provider shortage. Recently passed legislation (Chapter 305), championed by Senate President Therese Murray, addresses issues of access, quality and transparency in health care. The recognition of nurse practitioners as primary care providers is vital to this legislation and will immediately and dramatically increase the number of providers available to residents.
CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristin Emily Berry, DO 3640 Nw Samaritan Dr, Ste 270, Corvallis, OR 97330-3784 Ph: (541) 768-5300 | Dr Kristin Emily Berry, DO 340 Nw 5th St, Redmond, OR 97756-1869 Ph: (541) 526-6635 |
News Archive
CMC Biologics, Inc., a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, announced today that, as part of its global manufacturing capacity expansion strategy, it has completed the expansion of its North American manufacturing facility in Bothell, Washington with the addition of a single-use Bioreactor 6Pack™ facility.
Intense competition for posts has left many junior doctors (whose training costs around £237,000 each) without jobs to go to when their contracts end next Tuesday. Many are now considering leaving the country, abandoning the profession, or claiming unemployment benefit.
Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes.
Massachusetts has taken an important step towards addressing its primary care provider shortage. Recently passed legislation (Chapter 305), championed by Senate President Therese Murray, addresses issues of access, quality and transparency in health care. The recognition of nurse practitioners as primary care providers is vital to this legislation and will immediately and dramatically increase the number of providers available to residents.
CERAM Surface and Materials Analysis has published a white paper highlighting how surface analysis can expose counterfeit medicines. It describes how technologies such as X-ray photoelectron spectroscopy (XPS) and Time-of-Flight Secondary Ion Mass Spectroscopy (ToFSIMS) are being used in novel ways to not only analyse the composition of various pharmaceuticals, but also to determine differences in the manufacturing processes involved.
› Verified 7 days ago
Carol J. Darwish, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 340 Nw 5th St, Redmond, OR 97756 Phone: 541-526-6635 Fax: 541-526-6636 | |
Elizabeth Medora Murrill, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 340 Nw 5th St, Suite 101, Redmond, OR 97756 Phone: 541-526-6635 Fax: 541-526-6636 | |
Sarah N Hellmann, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 340 Nw 5th St, Redmond, OR 97756 Phone: 541-526-6635 | |
Laurie Doyon, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 340 Nw 5th St, Redmond, OR 97756 Phone: 541-526-6635 | |
Amy Yuan, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 340 Nw 5th St, Redmond, OR 97756 Phone: 541-526-6635 Fax: 541-526-6636 | |
Dr. Barbara S Newman, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 340 Nw 5th St, Suite 101, Redmond, OR 97756 Phone: 541-526-6635 Fax: 541-526-6636 |